AI assistant
Sending…
NANOVIRICIDES, INC. — Director's Dealing 2009
Dec 4, 2009
34915_dirs_2009-12-04_402485f2-609f-4bdd-95d8-57d5c903243c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NANOVIRICIDES, INC. (NNVC.OB)
CIK: 0001379006
Period of Report: 2009-11-30
Reporting Person: Theracour Pharma, Inc. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-11-30 | Common Stock | S | 20000 | $.85 | Disposed | 33602955 | Direct |
| 2009-12-01 | Common Stock | S | 15000 | $0.84 | Disposed | 33587955 | Direct |
| 2009-12-02 | Common Stock | S | 15000 | $.88 | Disposed | 33572955 | Direct |
| 2009-12-03 | Common Stock | S | 5000 | $.85 | Disposed | 33567955 | Direct |
Footnotes
F1: Represents shares of common stock sold in accordance with TheraCour's Rule 10b5-1 Trading Plan adopted with the Registrant as disclosed on Form 8-K on February 10, 2009.
More from NANOVIRICIDES, INC.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Interim / Quarterly Report
2026
Feb 17
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 22
Regulatory Filings
2025
Dec 16
Regulatory Filings
2025
Dec 15
Regulatory Filings
2025
Nov 26